AG真人官方

Paul McNab, EVP, Chief Marketing & Strategy Officer of Viavi Solutions Inc. (VIAV), reported equity transactions on 08/28/2025. The filing shows three installments of restricted stock units (RSUs) that converted upon vesting into 9,906, 12,879 and 18,739 shares; the company withheld 5,031, 6,540 and 9,517 shares to satisfy tax withholding at a stated price of $11.27 per share. The filing also reports an award of 44,378 RSUs and 44,378 market stock units (MSUs) granted on that date. Post-transaction beneficial ownership figures are listed for each line, for example 44,181, 39,150, 52,029, 45,489, 64,228 and 54,711 shares. The form is signed by an attorney-in-fact on 09/02/2025.

Ilan Daskal, EVP and CFO of Viavi Solutions (VIAV), received and settled equity awards tied to his compensation. On 08/28/2025, 55,115 restricted stock units (RSUs) converted into 55,115 shares of common stock and 24,857 shares were surrendered to the company to satisfy tax-withholding obligations from an RSU vesting, leaving 30,258 shares beneficially owned in the non-derivative table after the sale/withholding. The filing also reports outstanding equity awards: 110,228 RSU-equivalent shares reported following the conversion event and additional award balances of 142,258 RSUs and 142,258 market stock units (MSUs), each noted as having no expiration and vesting per the award schedules. The filing was signed by an attorney-in-fact on behalf of the reporting person.

Richard John Burns, a director of Viavi Solutions Inc. (VIAV), was granted 6,768 restricted stock units (RSUs) on 08/28/2025. The award carries a $0 purchase price and results in 6,768 shares of common stock beneficially owned following the transaction, held directly. The RSUs vest on the earlier of the one-year anniversary of the grant or the company鈥檚 next annual meeting of stockholders, and the RSUs have no expiration date. The Form 4 was signed by Donna T. Rossi as attorney-in-fact on 08/29/2025 and was filed as a single reporting person filing.

Viavi Solutions Inc. (VIAV) director Eugenia Corrales received an award of 6,768 restricted stock units (RSUs) on 08/28/2025. The RSUs were granted at a $0 exercise/conversion price and are reported as directly owned following the transaction, with 6,768 shares underlying the award. The units vest on the earlier of the one-year anniversary of the grant or the next annual meeting of stockholders, and the filing states there is no expiration date on the RSUs. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/29/2025.

Form 144 filed for Viavi Solutions Inc. (VIAV) shows a proposed sale of 13,115 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $146,560.13. The filing lists the number of outstanding shares as 223,245,915 and identifies the approximate date of sale as 08/29/2025 on NASDAQ. The securities were acquired on 08/28/2025 as restricted stock from the issuer, with payment dated 08/28/2025. The filer reports no securities sold in the past three months. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information and notes reliance possibilities for a Rule 10b5-1 trading plan if applicable. The issuer name and some filer contact details are not provided in the visible content.

Viavi Solutions Inc. (VIAV) submitted a Form 144 notice for a planned sale of 11,873 common shares valued at $132,693.84, to be executed approximately on 08/29/2025 on the NASDAQ. The shares represent a small portion of the company's common stock, with 223,245,915 shares outstanding, and were acquired as restricted stock from the issuer on 08/28/2025. The filing reports no sales by the seller in the past three months and indicates the transaction will be brokered by Morgan Stanley Smith Barney LLC. The filer attests they are not aware of undisclosed material adverse information and notes the usual Rule 10b5-1/attestation language on trading plans and criminal penalties for misstatements.

Viavi Solutions Inc. filed an 8-K reporting a material event and furnished two exhibits: an indenture dated August 20, 2025 between the company and U.S. Bank Trust Company, National Association as trustee, and the form of 0.625% Senior Convertible Notes due 2031 (included as part of the indenture). The filing lists the company鈥檚 principal contact information and is signed by Ilan Daskal, Chief Financial Officer, as the duly authorized officer. The exhibits indicate the company has documented the legal framework and the note terms for a convertible debt instrument carrying a stated interest rate of 0.625% and a 2031 maturity.